Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2024 Oct 1;159(10):1149-1156.
doi: 10.1001/jamasurg.2024.2487.

Venous Thromboembolism Prophylaxis in High-Risk Pediatric Trauma Patients

Amanda B Witte  1 , Kyle Van Arendonk  2 , Carisa Bergner  1 , Martin Bantchev  1 , Richard A Falcone Jr  3 , Suzanne Moody  3 , Heather A Hartman  4 , Emily Evans  4 , Rajan Thakkar  2 , Kelli N Patterson  2 , Peter C Minneci  5 , Grace Z Mak  6 , Mark B Slidell  7 , MacKenton Johnson  6 , Matthew P Landman  8 , Troy A Markel  8 , Charles M Leys  9 , Linda Cherney Stafford  9 , Jessica Draper  9 , David S Foley  10 , Cynthia Downard  10 , Tracy M Skaggs  10 , Dave R Lal  1 , David Gourlay  1 , Peter F Ehrlich  4
Affiliations
Multicenter Study

Venous Thromboembolism Prophylaxis in High-Risk Pediatric Trauma Patients

Amanda B Witte et al. JAMA Surg. .

Abstract

Importance: The indications, safety, and efficacy of chemical venous thromboembolism prophylaxis (cVTE) in pediatric trauma patients remain unclear. A set of high-risk criteria to guide cVTE use was recently recommended; however, these criteria have not been evaluated prospectively.

Objective: To examine high-risk criteria and cVTE use in a prospective multi-institutional study of pediatric trauma patients.

Design, setting, and participants: This cohort study was completed between October 2019 and October 2022 in 8 free-standing pediatric hospitals designated as American College of Surgeons level I pediatric trauma centers. Participants were pediatric trauma patients younger than 18 years who met defined high-risk criteria on admission. It was hypothesized that cVTE would be safe and reduce the incidence of VTE.

Exposures: Receipt and timing of chemical VTE prophylaxis.

Main outcomes and measures: The primary outcome was overall VTE rate stratified by receipt and timing of cVTE. The secondary outcome was safety of cVTE as measured by bleeding or other complications from anticoagulation.

Results: Among 460 high-risk pediatric trauma patients, the median (IQR) age was 14.5 years (10.4-16.2 years); 313 patients (68%) were male and 147 female (32%). The median (IQR) Injury Severity Score (ISS) was 23 (16-30), and median (IQR) number of high-risk factors was 3 (2-4). A total of 251 (54.5%) patients received cVTE; 62 (13.5%) received cVTE within 24 hours of admission. Patients who received cVTE after 24 hours had more high-risk factors and higher ISS. The most common reason for delayed cVTE was central nervous system bleed (120 patients; 30.2%). There were 28 VTE events among 25 patients (5.4%). VTE occurred in 1 of 62 patients (1.6%) receiving cVTE within 24 hours, 13 of 189 patients (6.9%) receiving cVTE after 24 hours, and 11 of 209 (5.3%) who had no cVTE (P = .31). Increasing time between admission and cVTE initiation was significantly associated with VTE (odds ratio, 1.01; 95% CI, 1.00-1.01; P = .01). No bleeding complications were observed while patients received cVTE.

Conclusions and relevance: In this prospective study, use of cVTE based on a set of high-risk criteria was safe and did not lead to bleeding complications. Delay to initiation of cVTE was significantly associated with development of VTE. Quality improvement in pediatric VTE prevention may center on timing of prophylaxis and barriers to implementation.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure.
Figure.. Timing of Chemical Venous Thromboembolism (cVTE) Prophylaxis and Development of VTE
See this image and copyright information in PMC

Comment on

References

    1. Georgeades C, Van Arendonk K, Gourlay D. Venous thromboembolism prophylaxis after pediatric trauma. Pediatr Surg Int. 2021;37(6):679-694. doi: 10.1007/s00383-020-04855-1 - DOI - PubMed
    1. Candrilli SD, Balkrishnan R, O’Brien SH. Effect of injury severity on the incidence and utilization-related outcomes of venous thromboembolism in pediatric trauma inpatients. Pediatr Crit Care Med. 2009;10(5):554-557. doi: 10.1097/PCC.0b013e3181a705d3 - DOI - PubMed
    1. Engel ER, Nguyen ATH, Amankwah EK, et al. Predictors of postthrombotic syndrome in pediatric thrombosis: a systematic review and meta-analysis of the literature. J Thromb Haemost. 2020;18(10):2601-2612. doi: 10.1111/jth.14984 - DOI - PubMed
    1. Yorkgitis BK, Berndtson AE, Cross A, et al. American Association for the Surgery of Trauma/American College of Surgeons Committee on Trauma Clinical Protocol for inpatient venous thromboembolism prophylaxis after trauma. J Trauma Acute Care Surg. 2022;92(3):597-604. doi: 10.1097/TA.0000000000003475 - DOI - PubMed
    1. Hanson SJ, Punzalan RC, Greenup RA, Liu H, Sato TT, Havens PL. Incidence and risk factors for venous thromboembolism in critically ill children after trauma. J Trauma. 2010;68(1):52-56. doi: 10.1097/TA.0b013e3181a74652 - DOI - PubMed